Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Dennis Ahnen

TitleAffiliate - VA
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED
Phone3033998020

    Collapse Research 
    Collapse research activities and funding
    T32DK007038     (ROSEN, HUGO RAMON)Jul 1, 1975 - Jun 30, 2021
    NIH/NIDDK
    Gastrointestinal Diseases Training Grant
    Role: Co-Principal Investigator

    R01AM033664     (AHNEN, DENNIS J)Apr 1, 1984 - Mar 31, 1987
    NIH/NIADDK
    MECHANISMS OF ENTEROCYTE SURFACE POLARITY IN VIVO
    Role: Principal Investigator

    R01DK033664     (AHNEN, DENNIS J)Apr 1, 1984 - Nov 30, 1992
    NIH/NIDDK
    MECHANISMS OF ENTEROCYTE CELL SURFACE POLARITY
    Role: Principal Investigator

    R01CA068099     (AHNEN, DENNIS J)Sep 30, 1995 - Jun 30, 2010
    NIH/NCI
    Promoting Colon Cancer Screening in High-Risk Families
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, Jemal A. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017 May 06; 67(3):177-193. PMID: 28248415.
      View in: PubMed
    2. Fedirko V, McKeown-Eyssen G, Serhan CN, Barry EL, Sandler RS, Figueiredo JC, Ahnen DJ, Bresalier RS, Robertson DJ, Anderson CW, Baron JA. Plasma lipoxin A4 and resolvin D1 are not associated with reduced adenoma risk in a randomized trial of aspirin to prevent colon adenomas. Mol Carcinog. 2017 Feb 20. PMID: 28218420.
      View in: PubMed
    3. Anderson JC, Baron JA, Ahnen DJ, Barry EL, Bostick RM, Burke CA, Bresalier RS, Church TR, Cole BF, Cruz-Correa M, Kim AS, Mott LA, Sandler RS, Robertson DJ. Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome. Gastroenterology. 2017 Jun; 152(8):1933-1943.e5. PMID: 28219690.
      View in: PubMed
    4. Jayasekara H, Reece JC, Buchanan DD, Ahnen DJ, Parry S, Jenkins MA, Win AK. Risk factors for metachronous colorectal cancer or polyp: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2017 Feb; 32(2):301-326. PMID: 27356122.
      View in: PubMed
    5. Hale VL, Chen J, Johnson S, Harrington SC, Yab TC, Smyrk TC, Nelson H, Boardman LA, Druliner BR, Levin TR, Rex DK, Ahnen DJ, Lance P, Ahlquist DA, Chia N. Shifts in the Fecal Microbiota Associated with Adenomatous Polyps. Cancer Epidemiol Biomarkers Prev. 2017 Jan; 26(1):85-94. PMID: 27672054.
      View in: PubMed
    6. Obuch JC, Ahnen DJ. Colorectal Cancer: Genetics is Changing Everything. Gastroenterol Clin North Am. 2016 09; 45(3):459-76. PMID: 27546843.
      View in: PubMed
    7. Thompson PA, Ashbeck EL, Roe DJ, Fales L, Buckmeier J, Wang F, Bhattacharyya A, Hsu CH, Chow HH, Ahnen DJ, Boland CR, Heigh RI, Fay DE, Hamilton SR, Jacobs ET, Martinez ME, Alberts DS, Lance P. Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes. J Natl Cancer Inst. 2016 Dec; 108(12). PMID: 27530657.
      View in: PubMed
    8. Thompson PA, Ashbeck EL, Roe DJ, Fales L, Buckmeier J, Wang F, Bhattacharyya A, Hsu CH, Chow SH, Ahnen DJ, Boland CR, Heigh RI, Fay DE, Hamilton SR, Jacobs ET, Martinez EM, Alberts DS, Lance P. Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial. J Natl Cancer Inst. 2016 Dec; 108(12). PMID: 27530656.
      View in: PubMed
    9. Provenzale D, Gupta S, Ahnen DJ, Bray T, Cannon JA, Cooper G, David DS, Early DS, Erwin D, Ford JM, Giardiello FM, Grady W, Halverson AL, Hamilton SR, Hampel H, Ismail MK, Klapman JB, Larson DW, Lazenby AJ, Lynch PM, Mayer RJ, Ness RM, Regenbogen SE, Samadder NJ, Shike M, Steinbach G, Weinberg D, Dwyer M, Darlow S. Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016 Aug; 14(8):1010-30. PMID: 27496117.
      View in: PubMed
    10. Ahnen DJ, Schroy PC, Weber TK. Regarding "Colorectal Cancer Screening Quality Measures: Beyond Colonoscopy". Clin Gastroenterol Hepatol. 2016 Nov; 14(11):1668-1669. PMID: 27266981.
      View in: PubMed
    11. Ricciardiello L, Ahnen DJ, Lynch PM. Chemoprevention of hereditary colon cancers: time for new strategies. Nat Rev Gastroenterol Hepatol. 2016 Jun; 13(6):352-61. PMID: 27095653.
      View in: PubMed
    12. Chau R, Dashti SG, Ait Ouakrim D, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Macrae FA, Boussioutas A, Parry S, Figueiredo JC, Levine AJ, Ahnen DJ, Casey G, Haile RW, Gallinger S, Le Marchand L, Thibodeau SN, Lindor NM, Newcomb PA, Potter JD, Baron JA, Hopper JL, Jenkins MA, Win AK. Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome. Int J Epidemiol. 2016 Jun; 45(3):940-53. PMID: 27063605.
      View in: PubMed
    13. Patel SG, Keswani R, Elta G, Saini S, Menard-Katcher P, Del Valle J, Hosford L, Myers A, Ahnen D, Schoenfeld P, Wani S. Corrigendum: Status of Competency-Based Medical Education in Endoscopy Training: A Nationwide Survey of US ACGME-Accredited Gastroenterology Training Programs. Am J Gastroenterol. 2016 Apr; 111(4):585. PMID: 27125721.
      View in: PubMed
    14. Pohl H, Robertson DJ, Mott LA, Ahnen DJ, Burke CA, Barry EL, Bresalier RS, Figueiredo JC, Shaukat A, Sandler RS, Baron JA. Association between adenoma location and risk of recurrence. Gastrointest Endosc. 2016 Oct; 84(4):709-16. PMID: 26975233.
      View in: PubMed
    15. Lynch PM, Morris JS, Wen S, Advani SM, Ross W, Chang GJ, Rodriguez-Bigas M, Raju GS, Ricciardiello L, Iwama T, Rossi BM, Pellise M, Stoffel E, Wise PE, Bertario L, Saunders B, Burt R, Belluzzi A, Ahnen D, Matsubara N, Bülow S, Jespersen N, Clark SK, Erdman SH, Markowitz AJ, Bernstein I, De Haas N, Syngal S, Moeslein G. A proposed staging system and stage-specific interventions for familial adenomatous polyposis. Gastrointest Endosc. 2016 Jul; 84(1):115-125.e4. PMID: 26769407.
      View in: PubMed
    16. Imler TD, Morea J, Kahi C, Cardwell J, Johnson CS, Xu H, Ahnen D, Antaki F, Ashley C, Baffy G, Cho I, Dominitz J, Hou J, Korsten M, Nagar A, Promrat K, Robertson D, Saini S, Shergill A, Smalley W, Imperiale TF. Corrigendum: Multi-Center Colonoscopy Quality Measurement Utilizing Natural Language Processing. Am J Gastroenterol. 2015 Dec; 110(12):1743. PMID: 26673514.
      View in: PubMed
    17. Patel SG, Schoenfeld P, Kim HM, Ward EK, Bansal A, Kim Y, Hosford L, Myers A, Foster S, Craft J, Shopinski S, Wilson RH, Ahnen DJ, Rastogi A, Wani S. Real-Time Characterization of Diminutive Colorectal Polyp Histology Using Narrow-Band Imaging: Implications for the Resect and Discard Strategy. Gastroenterology. 2016 Feb; 150(2):406-18. PMID: 26522260; PMCID: PMC4940991.
    18. Levine AJ, Phipps AI, Baron JA, Buchanan DD, Ahnen DJ, Cohen SA, Lindor NM, Newcomb PA, Rosty C, Haile RW, Laird PW, Weisenberger DJ. Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors. Cancer Epidemiol Biomarkers Prev. 2016 Jan; 25(1):68-75. PMID: 26512054; PMCID: PMC4713308 [Available on 01/01/17].
    19. Baron JA, Barry EL, Mott LA, Rees JR, Sandler RS, Snover DC, Bostick RM, Ivanova A, Cole BF, Ahnen DJ, Beck GJ, Bresalier RS, Burke CA, Church TR, Cruz-Correa M, Figueiredo JC, Goodman M, Kim AS, Robertson DJ, Rothstein R, Shaukat A, Seabrook ME, Summers RW. A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas. N Engl J Med. 2015 Oct 15; 373(16):1519-30. PMID: 26465985; PMCID: PMC4643064.
    20. Peery AF, Sandler RS, Galanko JA, Bresalier RS, Figueiredo JC, Ahnen DJ, Barry EL, Baron JA. Risk Factors for Hemorrhoids on Screening Colonoscopy. PLoS One. 2015; 10(9):e0139100. PMID: 26406337; PMCID: PMC4583402.
    21. Fedirko V, Bradshaw PT, Figueiredo JC, Sandler RS, Barry EL, Ahnen DJ, Milne GL, Bresalier RS, Baron JA. Urinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS). Cancer Prev Res (Phila). 2015 Nov; 8(11):1061-8. PMID: 26304466; PMCID: PMC4633350 [Available on 11/01/16].
    22. Provenzale D, Jasperson K, Ahnen DJ, Aslanian H, Bray T, Cannon JA, David DS, Early DS, Erwin D, Ford JM, Giardiello FM, Gupta S, Halverson AL, Hamilton SR, Hampel H, Ismail MK, Klapman JB, Larson DW, Lazenby AJ, Lynch PM, Mayer RJ, Ness RM, Rao MS, Regenbogen SE, Shike M, Steinbach G, Weinberg D, Dwyer MA, Freedman-Cass DA, Darlow S. Colorectal Cancer Screening, Version 1.2015. J Natl Compr Canc Netw. 2015 Aug; 13(8):959-68; quiz 968. PMID: 26285241.
      View in: PubMed
    23. Samadder NJ, Smith KR, Hanson H, Pimentel R, Wong J, Boucher K, Ahnen D, Singh H, Ulrich CM, Burt RW, Curtin K. Increased Risk of Colorectal Cancer Among Family Members of All Ages, Regardless of Age of Index Case at Diagnosis. Clin Gastroenterol Hepatol. 2015 Dec; 13(13):2305-11.e1-2. PMID: 26188136.
      View in: PubMed
    24. Dashti SG, Chau R, Ouakrim DA, Buchanan DD, Clendenning M, Young JP, Winship IM, Arnold J, Ahnen DJ, Haile RW, Casey G, Gallinger S, Thibodeau SN, Lindor NM, Le Marchand L, Newcomb PA, Potter JD, Baron JA, Hopper JL, Jenkins MA, Win AK. Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome. JAMA. 2015 Jul 07; 314(1):61-71. PMID: 26151267; PMCID: PMC4688894.
    25. Ait Ouakrim D, Dashti SG, Chau R, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Leggett B, Macrae FA, Ahnen DJ, Casey G, Gallinger S, Haile RW, Le Marchand L, Thibodeau SN, Lindor NM, Newcomb PA, Potter JD, Baron JA, Hopper JL, Jenkins MA, Win AK. Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome. J Natl Cancer Inst. 2015 Sep; 107(9). PMID: 26109217; PMCID: PMC4651105.
    26. Campbell PT, Newton CC, Newcomb PA, Phipps AI, Ahnen DJ, Baron JA, Buchanan DD, Casey G, Cleary SP, Cotterchio M, Farris AB, Figueiredo JC, Gallinger S, Green RC, Haile RW, Hopper JL, Jenkins MA, Le Marchand L, Makar KW, McLaughlin JR, Potter JD, Renehan AG, Sinicrope FA, Thibodeau SN, Ulrich CM, Win AK, Lindor NM, Limburg PJ. Association between body mass index and mortality for colorectal cancer survivors: overall and by tumor molecular phenotype. Cancer Epidemiol Biomarkers Prev. 2015 Aug; 24(8):1229-38. PMID: 26038390; PMCID: PMC4526409.
    27. Phipps AI, Ahnen DJ, Cheng I, Newcomb PA, Win AK, Burnett T. PIK3CA Somatic Mutation Status in Relation to Patient and Tumor Factors in Racial/Ethnic Minorities with Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2015 Jul; 24(7):1046-51. PMID: 25994739; PMCID: PMC4490937.
    28. Patel SG, Keswani R, Elta G, Saini S, Menard-Katcher P, Del Valle J, Hosford L, Myers A, Ahnen D, Schoenfeld P, Wani S. Status of Competency-Based Medical Education in Endoscopy Training: A Nationwide Survey of US ACGME-Accredited Gastroenterology Training Programs. Am J Gastroenterol. 2015 Jul; 110(7):956-62. PMID: 25803401.
      View in: PubMed
    29. Henry CJ, Sedjo RL, Rozhok A, Salstrom J, Ahnen D, Levin TR, D'Agostino R, Haffner S, DeGregori J, Byers T. Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenoma. BMC Cancer. 2015 Mar 14; 15:123. PMID: 25884547; PMCID: PMC4359784.
    30. Imler TD, Morea J, Kahi C, Sherer EA, Cardwell J, Johnson CS, Xu H, Ahnen D, Antaki F, Ashley C, Baffy G, Cho I, Dominitz J, Hou J, Korsten M, Nagar A, Promrat K, Robertson D, Saini S, Shergill A, Smalley W, Imperiale TF. Multi-center colonoscopy quality measurement utilizing natural language processing. Am J Gastroenterol. 2015 Apr; 110(4):543-52. PMID: 25756240.
      View in: PubMed
    31. Ahnen DJ, Bresalier RS, Levin B, Kaunitz JD. CRC screening, past, present, and future: a tribute to Emmet Keeffe. Dig Dis Sci. 2015 Mar; 60(3):589-91. PMID: 25724168; PMCID: PMC4428673.
    32. Obuch JC, Pigott CM, Ahnen DJ. Sessile serrated polyps: detection, eradication, and prevention of the evil twin. Curr Treat Options Gastroenterol. 2015 Mar; 13(1):156-70. PMID: 25623474; PMCID: PMC4427517.
    33. Patel SG, Lowery JT, Gatof D, Ahnen DJ. Practical opportunities to improve early detection and prevention of colorectal cancer (CRC) in members of high-risk families. Dig Dis Sci. 2015 Mar; 60(3):748-61. PMID: 25698379.
      View in: PubMed
    34. Samadder NJ, Smith KR, Mineau GP, Pimentel R, Wong J, Boucher K, Pappas L, Singh H, Ahnen D, Burt RW, Curtin K. Familial colorectal cancer risk by subsite of primary cancer: a population-based study in Utah. Aliment Pharmacol Ther. 2015 Mar; 41(6):573-80. PMID: 25604623.
      View in: PubMed
    35. Weisenberger DJ, Levine AJ, Long TI, Buchanan DD, Walters R, Clendenning M, Rosty C, Joshi AD, Stern MC, Le Marchand L, Lindor NM, Daftary D, Gallinger S, Selander T, Bapat B, Newcomb PA, Campbell PT, Casey G, Ahnen DJ, Baron JA, Haile RW, Hopper JL, Young JP, Laird PW, Siegmund KD. Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history. Cancer Epidemiol Biomarkers Prev. 2015 Mar; 24(3):512-9. PMID: 25587051; PMCID: PMC4355081.
    36. Wolf HJ, Dwyer A, Ahnen DJ, Pray SL, Rein SM, Morwood KD, Lowery JT, Masias A, Collins NJ, Brown CE, DeMaio Goheen CA, McAbee KE, Sauaia A, Byers TE. Colon cancer screening for Colorado's underserved: a community clinic/academic partnership. Am J Prev Med. 2015 Mar; 48(3):264-70. PMID: 25547926.
      View in: PubMed
    37. Figueiredo JC, Crockett SD, Snover DC, Morris CB, McKeown-Eyssen G, Sandler RS, Ahnen DJ, Robertson DJ, Burke CA, Bresalier RS, Church JM, Church TR, Baron JA. Smoking-associated risks of conventional adenomas and serrated polyps in the colorectum. Cancer Causes Control. 2015 Mar; 26(3):377-86. PMID: 25537738; PMCID: PMC4331601.
    38. Wallace K, Burke CA, Ahnen DJ, Barry EL, Bresalier RS, Saibil F, Baron JA. The association of age and race and the risk of large bowel polyps. Cancer Epidemiol Biomarkers Prev. 2015 Feb; 24(2):448-53. PMID: 25490989; PMCID: PMC4487651.
    39. Barry EL, Mott LA, Melamed ML, Rees JR, Ivanova A, Sandler RS, Ahnen DJ, Bresalier RS, Summers RW, Bostick RM, Baron JA. Calcium supplementation increases blood creatinine concentration in a randomized controlled trial. PLoS One. 2014; 9(10):e108094. PMID: 25329821; PMCID: PMC4198086.
    40. Barry EL, Rees JR, Peacock JL, Mott LA, Amos CI, Bostick RM, Figueiredo JC, Ahnen DJ, Bresalier RS, Burke CA, Baron JA. Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial. J Clin Endocrinol Metab. 2014 Oct; 99(10):E2133-7. PMID: 25070320; PMCID: PMC4184076.
    41. Phipps AI, Ahnen DJ, Campbell PT, Win AK, Jenkins MA, Lindor NM, Gryfe R, Potter JD, Newcomb PA. Family history of colorectal cancer is not associated with colorectal cancer survival regardless of microsatellite instability status. Cancer Epidemiol Biomarkers Prev. 2014 Aug; 23(8):1700-4. PMID: 24891550; PMCID: PMC4119483.
    42. Crockett SD, Snover DC, Ahnen DJ, Baron JA. Reply: To PMID 24216467. Clin Gastroenterol Hepatol. 2014 Jul; 12(7):1203. PMID: 24727545.
      View in: PubMed
    43. Win AK, Buchanan DD, Rosty C, MacInnis RJ, Dowty JG, Dite GS, Giles GG, Southey MC, Young JP, Clendenning M, Walsh MD, Walters RJ, Boussioutas A, Smyrk TC, Thibodeau SN, Baron JA, Potter JD, Newcomb PA, Le Marchand L, Haile RW, Gallinger S, Lindor NM, Hopper JL, Ahnen DJ, Jenkins MA. Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives. Gut. 2015 Jan; 64(1):101-10. PMID: 24615377; PMCID: PMC4180004.
    44. Lowery JT, Horick N, Kinney AY, Finkelstein DM, Garrett K, Haile RW, Lindor NM, Newcomb PA, Sandler RS, Burke C, Hill DA, Ahnen DJ. A randomized trial to increase colonoscopy screening in members of high-risk families in the colorectal cancer family registry and cancer genetics network. Cancer Epidemiol Biomarkers Prev. 2014 Apr; 23(4):601-10. PMID: 24501379; PMCID: PMC3976708.
    45. Ahnen DJ, Wade SW, Jones WF, Sifri R, Mendoza Silveiras J, Greenamyer J, Guiffre S, Axilbund J, Spiegel A, You YN. The increasing incidence of young-onset colorectal cancer: a call to action. Mayo Clin Proc. 2014 Feb; 89(2):216-24. PMID: 24393412.
      View in: PubMed
    46. Biancolella M, Fortini BK, Tring S, Plummer SJ, Mendoza-Fandino GA, Hartiala J, Hitchler MJ, Yan C, Schumacher FR, Conti DV, Edlund CK, Noushmehr H, Coetzee SG, Bresalier RS, Ahnen DJ, Barry EL, Berman BP, Rice JC, Coetzee GA, Casey G. Identification and characterization of functional risk variants for colorectal cancer mapping to chromosome 11q23.1. Hum Mol Genet. 2014 Apr 15; 23(8):2198-209. PMID: 24256810; PMCID: PMC3959808.
    47. Crockett SD, Snover DC, Ahnen DJ, Baron JA. Sessile serrated adenomas: an evidence-based guide to management. Clin Gastroenterol Hepatol. 2015 Jan; 13(1):11-26.e1. PMID: 24216467.
      View in: PubMed
    48. Peery AF, Sandler RS, Ahnen DJ, Galanko JA, Holm AN, Shaukat A, Mott LA, Barry EL, Fried DA, Baron JA. Constipation and a low-fiber diet are not associated with diverticulosis. Clin Gastroenterol Hepatol. 2013 Dec; 11(12):1622-7. PMID: 23891924; PMCID: PMC3840096.
    49. Robertson DJ, Lieberman DA, Winawer SJ, Ahnen DJ, Baron JA, Schatzkin A, Cross AJ, Zauber AG, Church TR, Lance P, Greenberg ER, Martínez ME. Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut. 2014 Jun; 63(6):949-56. PMID: 23793224; PMCID: PMC4383397.
    50. Walters RJ, Williamson EJ, English DR, Young JP, Rosty C, Clendenning M, Walsh MD, Parry S, Ahnen DJ, Baron JA, Win AK, Giles GG, Hopper JL, Jenkins MA, Buchanan DD. Association between hypermethylation of DNA repetitive elements in white blood cell DNA and early-onset colorectal cancer. Epigenetics. 2013 Jul; 8(7):748-55. PMID: 23804018; PMCID: PMC3781194.
    51. Adams SV, Ahnen DJ, Baron JA, Campbell PT, Gallinger S, Grady WM, LeMarchand L, Lindor NM, Potter JD, Newcomb PA. Survival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family Registry. World J Gastroenterol. 2013 Jun 07; 19(21):3241-8. PMID: 23745025; PMCID: PMC3671075.
    52. Keogh LA, Fisher D, Sheinfeld Gorin S, Schully SD, Lowery JT, Ahnen DJ, Maskiell JA, Lindor NM, Hopper JL, Burnett T, Holter S, Arnold JL, Gallinger S, Laurino M, Esplen MJ, Sinicrope PS. How do researchers manage genetic results in practice? The experience of the multinational Colon Cancer Family Registry. J Community Genet. 2014 Apr; 5(2):99-108. PMID: 23703702; PMCID: PMC3955463.
    53. Patel SG, Ahnen DJ. Prevention of interval colorectal cancers: what every clinician needs to know. Clin Gastroenterol Hepatol. 2014 Jan; 12(1):7-15. PMID: 23639602.
      View in: PubMed
    54. Martínez ME, Ahnen D, Greenberg ER. One-year risk for advanced colorectal neoplasia. Ann Intern Med. 2013 Apr 16; 158(8):639. PMID: 23588762.
      View in: PubMed
    55. Jiang X, Castelao JE, Vandenberg D, Carracedo A, Redondo CM, Conti DV, Paredes Cotoré JP, Potter JD, Newcomb PA, Passarelli MN, Jenkins MA, Hopper JL, Gallinger S, Le Marchand L, Martínez ME, Ahnen DJ, Baron JA, Lindor NM, Haile RW, Gago-Dominguez M. Genetic variations in SMAD7 are associated with colorectal cancer risk in the colon cancer family registry. PLoS One. 2013; 8(4):e60464. PMID: 23560096; PMCID: PMC3616155.
    56. Patel SG, Rastogi A, Austin G, Hall M, Siller BA, Berman K, Yen R, Bansal A, Ahnen DJ, Wani S. Gastroenterology trainees can easily learn histologic characterization of diminutive colorectal polyps with narrow band imaging. Clin Gastroenterol Hepatol. 2013 Aug; 11(8):997-1003.e1. PMID: 23466714.
      View in: PubMed
    57. Dowty JG, Win AK, Buchanan DD, Lindor NM, Macrae FA, Clendenning M, Antill YC, Thibodeau SN, Casey G, Gallinger S, Marchand LL, Newcomb PA, Haile RW, Young GP, James PA, Giles GG, Gunawardena SR, Leggett BA, Gattas M, Boussioutas A, Ahnen DJ, Baron JA, Parry S, Goldblatt J, Young JP, Hopper JL, Jenkins MA. Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat. 2013 Mar; 34(3):490-7. PMID: 23255516; PMCID: PMC3887142.
    58. Win AK, Lindor NM, Winship I, Tucker KM, Buchanan DD, Young JP, Rosty C, Leggett B, Giles GG, Goldblatt J, Macrae FA, Parry S, Kalady MF, Baron JA, Ahnen DJ, Marchand LL, Gallinger S, Haile RW, Newcomb PA, Hopper JL, Jenkins MA. Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. J Natl Cancer Inst. 2013 Feb 20; 105(4):274-9. PMID: 23385444; PMCID: PMC3576323.
    59. Win AK, Parry S, Parry B, Kalady MF, Macrae FA, Ahnen DJ, Young GP, Lipton L, Winship I, Boussioutas A, Young JP, Buchanan DD, Arnold J, Le Marchand L, Newcomb PA, Haile RW, Lindor NM, Gallinger S, Hopper JL, Jenkins MA. Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers. Ann Surg Oncol. 2013 Jun; 20(6):1829-36. PMID: 23358792; PMCID: PMC4041733.
    60. Martínez ME, Thompson P, Messer K, Ashbeck EL, Lieberman DA, Baron JA, Ahnen DJ, Robertson DJ, Jacobs ET, Greenberg ER, Cross AJ, Atkin W. One-year risk for advanced colorectal neoplasia: U.S. versus U.K. risk-stratification guidelines. Ann Intern Med. 2012 Dec 18; 157(12):856-64. PMID: 23247939; PMCID: PMC3787691.
    61. Austin GL, Fennimore B, Ahnen DJ. Can colonoscopy remain cost-effective for colorectal cancer screening? The impact of practice patterns and the Will Rogers phenomenon on costs. Am J Gastroenterol. 2013 Mar; 108(3):296-301. PMID: 23208273.
      View in: PubMed
    62. Barry EL, Poole EM, Baron JA, Makar KW, Mott LA, Sandler RS, Ahnen DJ, Bresalier RS, McKeown-Eyssen GE, Ulrich CM. CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment. Cancer Causes Control. 2013 Jan; 24(1):47-54. PMID: 23081681; PMCID: PMC3529799.
    63. Moreira L, Balaguer F, Lindor N, de la Chapelle A, Hampel H, Aaltonen LA, Hopper JL, Le Marchand L, Gallinger S, Newcomb PA, Haile R, Thibodeau SN, Gunawardena S, Jenkins MA, Buchanan DD, Potter JD, Baron JA, Ahnen DJ, Moreno V, Andreu M, Ponz de Leon M, Rustgi AK, Castells A. Identification of Lynch syndrome among patients with colorectal cancer. JAMA. 2012 Oct 17; 308(15):1555-65. PMID: 23073952; PMCID: PMC3873721.
    64. Thompson P, Roe DJ, Fales L, Buckmeier J, Wang F, Hamilton SR, Bhattacharyya A, Green S, Hsu CH, Chow HH, Ahnen DJ, Boland CR, Heigh RI, Fay DE, Martinez ME, Jacobs E, Ashbeck EL, Alberts DS, Lance P. Design and baseline characteristics of participants in a phase III randomized trial of celecoxib and selenium for colorectal adenoma prevention. Cancer Prev Res (Phila). 2012 Dec; 5(12):1381-93. PMID: 23060037; PMCID: PMC3518663.
    65. Patel SG, Ahnen DJ. Familial colon cancer syndromes: an update of a rapidly evolving field. Curr Gastroenterol Rep. 2012 Oct; 14(5):428-38. PMID: 22864806; PMCID: PMC3448005.
    66. Macrae F, Ahnen DJ. Acceleration in colorectal carcinogenesis: the hare, the tortoise or myth? Gut. 2013 May; 62(5):657-9. PMID: 22961679.
      View in: PubMed
    67. Phipps AI, Buchanan DD, Makar KW, Burnett-Hartman AN, Coghill AE, Passarelli MN, Baron JA, Ahnen DJ, Win AK, Potter JD, Newcomb PA. BRAF mutation status and survival after colorectal cancer diagnosis according to patient and tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2012 Oct; 21(10):1792-8. PMID: 22899730; PMCID: PMC3467328.
    68. Rex DK, Ahnen DJ, Baron JA, Batts KP, Burke CA, Burt RW, Goldblum JR, Guillem JG, Kahi CJ, Kalady MF, O'Brien MJ, Odze RD, Ogino S, Parry S, Snover DC, Torlakovic EE, Wise PE, Young J, Church J. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol. 2012 Sep; 107(9):1315-29; quiz 1314, 1330. PMID: 22710576; PMCID: PMC3629844.
    69. Lanspa SJ, Ahnen DJ, Lynch HT. Serrated polyposis: the last (or only the latest?) frontier of familial polyposis? Am J Gastroenterol. 2012 May; 107(5):779-81. PMID: 22552244.
      View in: PubMed
    70. Win AK, Young JP, Lindor NM, Tucker KM, Ahnen DJ, Young GP, Buchanan DD, Clendenning M, Giles GG, Winship I, Macrae FA, Goldblatt J, Southey MC, Arnold J, Thibodeau SN, Gunawardena SR, Bapat B, Baron JA, Casey G, Gallinger S, Le Marchand L, Newcomb PA, Haile RW, Hopper JL, Jenkins MA. Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol. 2012 Mar 20; 30(9):958-64. PMID: 22331944; PMCID: PMC3341109.
    71. Walsh MD, Buchanan DD, Pearson SA, Clendenning M, Jenkins MA, Win AK, Walters RJ, Spring KJ, Nagler B, Pavluk E, Arnold ST, Goldblatt J, George J, Suthers GK, Phillips K, Hopper JL, Jass JR, Baron JA, Ahnen DJ, Thibodeau SN, Lindor N, Parry S, Walker NI, Rosty C, Young JP. Immunohistochemical testing of conventional adenomas for loss of expression of mismatch repair proteins in Lynch syndrome mutation carriers: a case series from the Australasian site of the colon cancer family registry. Mod Pathol. 2012 May; 25(5):722-30. PMID: 22322191; PMCID: PMC3477239.
    72. Lowery JT, Marcus A, Kinney A, Bowen D, Finkelstein DM, Horick N, Garrett K, Haile R, Sandler R, Ahnen DJ. The Family Health Promotion Project (FHPP): design and baseline data from a randomized trial to increase colonoscopy screening in high risk families. Contemp Clin Trials. 2012 Mar; 33(2):426-35. PMID: 22101228; PMCID: PMC4303240.
    73. Neklason DW, Done MW, Sargent NR, Schwartz AG, Anton-Culver H, Griffin CA, Ahnen DJ, Schildkraut JM, Tomlinson GE, Strong LC, Miller AR, Stopfer JE, Burt RW. Activating mutation in MET oncogene in familial colorectal cancer. BMC Cancer. 2011 Oct 04; 11:424. PMID: 21970370; PMCID: PMC3202244.
    74. Patel SG, Ahnen DJ. Isn't it time to stop talking about colonoscopy quality and start doing something about it? Dig Dis Sci. 2011 Oct; 56(10):2776-9. PMID: 21863330.
      View in: PubMed
    75. Barry EL, Mott LA, Sandler RS, Ahnen DJ, Baron JA. Variants downstream of the ornithine decarboxylase gene influence risk of colorectal adenoma and aspirin chemoprevention. Cancer Prev Res (Phila). 2011 Dec; 4(12):2072-82. PMID: 21930798; PMCID: PMC3232321.
    76. Wang J, Joshi AD, Corral R, Siegmund KD, Marchand LL, Martinez ME, Haile RW, Ahnen DJ, Sandler RS, Lance P, Stern MC. Carcinogen metabolism genes, red meat and poultry intake, and colorectal cancer risk. Int J Cancer. 2012 Apr 15; 130(8):1898-907. PMID: 21618522; PMCID: PMC3883510.
    77. Win AK, Dowty JG, English DR, Campbell PT, Young JP, Winship I, Macrae FA, Lipton L, Parry S, Young GP, Buchanan DD, Martínez ME, Jacobs ET, Ahnen DJ, Haile RW, Casey G, Baron JA, Lindor NM, Thibodeau SN, Newcomb PA, Potter JD, Le Marchand L, Gallinger S, Hopper JL, Jenkins MA. Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes. Br J Cancer. 2011 Jun 28; 105(1):162-9. PMID: 21559014; PMCID: PMC3137400.
    78. Ahnen DJ. The American College of Gastroenterology Emily Couric Lecture--the adenoma-carcinoma sequence revisited: has the era of genetic tailoring finally arrived? Am J Gastroenterol. 2011 Feb; 106(2):190-8. PMID: 21266962.
      View in: PubMed
    79. Austin GL, Goldstein JI, Peters SL, Ahnen DJ. Are colorectal cancer screening recommendations for first-degree relatives of patients with adenomas too aggressive? Clin Gastroenterol Hepatol. 2011 Apr; 9(4):308-13. PMID: 21238609.
      View in: PubMed
    80. Sedjo RL, D'Agostino RB, Ahnen D, Levin TR, Haffner SM, Tooze JA, Byers T. Lack of association between insulin sensitivity and colorectal adenoma risk. Nutr Cancer. 2011; 63(1):6-11. PMID: 21154114; PMCID: PMC3752663.
    81. Wallace K, Grau MV, Levine AJ, Shen L, Hamdan R, Chen X, Gui J, Haile RW, Barry EL, Ahnen D, McKeown-Eyssen G, Baron JA, Issa JP. Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa. Cancer Prev Res (Phila). 2010 Dec; 3(12):1552-64. PMID: 21149331; PMCID: PMC3058541.
    82. Brevik A, Joshi AD, Corral R, Onland-Moret NC, Siegmund KD, Le Marchand L, Baron JA, Martinez ME, Haile RW, Ahnen DJ, Sandler RS, Lance P, Stern MC. Polymorphisms in base excision repair genes as colorectal cancer risk factors and modifiers of the effect of diets high in red meat. Cancer Epidemiol Biomarkers Prev. 2010 Dec; 19(12):3167-73. PMID: 21037106; PMCID: PMC3058341.
    83. Ahnen DJ. Colorectal cancer: what to do when logic and good intentions are not enough. Dig Dis Sci. 2010 May; 55(5):1194-6. PMID: 20414805.
      View in: PubMed
    84. Pangburn HA, Ahnen DJ, Rice PL. Sulindac metabolites induce proteosomal and lysosomal degradation of the epidermal growth factor receptor. Cancer Prev Res (Phila). 2010 Apr; 3(4):560-72. PMID: 20332299.
      View in: PubMed
    85. Gellad ZF, Weiss DG, Ahnen DJ, Lieberman DA, Jackson GL, Provenzale D. Colonoscopy withdrawal time and risk of neoplasia at 5 years: results from VA Cooperative Studies Program 380. Am J Gastroenterol. 2010 Aug; 105(8):1746-52. PMID: 20234348; PMCID: PMC3729935.
    86. Garg S, Ahnen DJ. Is computed tomographic colonography being held to a higher standard? Ann Intern Med. 2010 Feb 02; 152(3):178-81. PMID: 20124234.
      View in: PubMed
    87. Ahnen DJ, Byers T. Editorial: Colorectal cancer and statins: reflections from the end of the road. Am J Gastroenterol. 2009 Dec; 104(12):3024-6. PMID: 19956119.
      View in: PubMed
    88. Ho GY, Xue X, Cushman M, McKeown-Eyssen G, Sandler RS, Ahnen DJ, Barry EL, Saibil F, Bresalier RS, Rohan TE, Baron JA. Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas. J Natl Cancer Inst. 2009 Dec 02; 101(23):1650-4. PMID: 19822838; PMCID: PMC2786916.
    89. Barry EL, Sansbury LB, Grau MV, Ali IU, Tsang S, Munroe DJ, Ahnen DJ, Sandler RS, Saibil F, Gui J, Bresalier RS, McKeown-Eyssen GE, Burke C, Baron JA. Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 2009 Oct; 18(10):2726-33. PMID: 19755647; PMCID: PMC2769932.
    90. Wallace K, Grau MV, Ahnen D, Snover DC, Robertson DJ, Mahnke D, Gui J, Barry EL, Summers RW, McKeown-Eyssen G, Haile RW, Baron JA. The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum. Cancer Epidemiol Biomarkers Prev. 2009 Aug; 18(8):2310-7. PMID: 19661090; PMCID: PMC3669681.
    91. Robertson DJ, Burke CA, Welch HG, Haile RW, Sandler RS, Greenberg ER, Ahnen DJ, Bresalier RS, Rothstein RI, Cole B, Mott LA, Baron JA. Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics. Ann Intern Med. 2009 Jul 21; 151(2):103-9. PMID: 19620162; PMCID: PMC2779048.
    92. Bapat B, Lindor NM, Baron J, Siegmund K, Li L, Zheng Y, Haile R, Gallinger S, Jass JR, Young JP, Cotterchio M, Jenkins M, Grove J, Casey G, Thibodeau SN, Bishop DT, Hopper JL, Ahnen D, Newcomb PA, Le Marchand L, Potter JD, Seminara D. The association of tumor microsatellite instability phenotype with family history of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2009 Mar; 18(3):967-75. PMID: 19258475; PMCID: PMC2763617.
    93. Ahnen DJ, Lieberman DA. Colonoscopy training for nurse endoscopists: is it possible? Is it wise? Is it worth doing? Gastrointest Endosc. 2009 Mar; 69(3 Pt 2):696-9. PMID: 19251012.
      View in: PubMed
    94. Grau MV, Sandler RS, McKeown-Eyssen G, Bresalier RS, Haile RW, Barry EL, Ahnen DJ, Gui J, Summers RW, Baron JA. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study. J Natl Cancer Inst. 2009 Feb 18; 101(4):267-76. PMID: 19211442; PMCID: PMC2644329.
    95. Jacobs ET, Ahnen DJ, Ashbeck EL, Baron JA, Greenberg ER, Lance P, Lieberman DA, McKeown-Eyssen G, Schatzkin A, Thompson PA, Martínez ME. Association between body mass index and colorectal neoplasia at follow-up colonoscopy: a pooling study. Am J Epidemiol. 2009 Mar 15; 169(6):657-66. PMID: 19147743; PMCID: PMC2727215.
    96. Martínez ME, Baron JA, Lieberman DA, Schatzkin A, Lanza E, Winawer SJ, Zauber AG, Jiang R, Ahnen DJ, Bond JH, Church TR, Robertson DJ, Smith-Warner SA, Jacobs ET, Alberts DS, Greenberg ER. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology. 2009 Mar; 136(3):832-41. PMID: 19171141; PMCID: PMC3685417.
    97. Joshi AD, Corral R, Siegmund KD, Haile RW, Le Marchand L, Martínez ME, Ahnen DJ, Sandler RS, Lance P, Stern MC. Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk. Carcinogenesis. 2009 Mar; 30(3):472-9. PMID: 19029193; PMCID: PMC2722151.
    98. Messersmith WA, Ahnen DJ. Targeting EGFR in colorectal cancer. N Engl J Med. 2008 Oct 23; 359(17):1834-6. PMID: 18946069.
      View in: PubMed
    99. Zou H, Taylor WR, Harrington JJ, Hussain FT, Cao X, Loprinzi CL, Levine TR, Rex DK, Ahnen D, Knigge KL, Lance P, Jiang X, Smith DI, Ahlquist DA. High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay. Gastroenterology. 2009 Feb; 136(2):459-70. PMID: 19026650.
      View in: PubMed
    100. Ahlquist DA, Sargent DJ, Loprinzi CL, Levin TR, Rex DK, Ahnen DJ, Knigge K, Lance MP, Burgart LJ, Hamilton SR, Allison JE, Lawson MJ, Devens ME, Harrington JJ, Hillman SL. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med. 2008 Oct 07; 149(7):441-50, W81. PMID: 18838724; PMCID: PMC4016975.
    101. Figueiredo JC, Levine AJ, Grau MV, Barry EL, Ueland PM, Ahnen DJ, Byers T, Bresalier RS, Summers RW, Bond J, McKeown-Eyssen GE, Sandler RS, Haile RW, Baron JA. Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels. Cancer Epidemiol Biomarkers Prev. 2008 Oct; 17(10):2625-31. PMID: 18843003; PMCID: PMC2597215.
    102. Groff RJ, Nash R, Ahnen DJ. Significance of serrated polyps of the colon. Curr Gastroenterol Rep. 2008 Oct; 10(5):490-8. PMID: 18799125; PMCID: PMC3437745.
    103. Robertson DJ, Sandler RS, Ahnen DJ, Greenberg ER, Mott LA, Cole BF, Baron JA. Gastrin, Helicobacter pylori, and colorectal adenomas. Clin Gastroenterol Hepatol. 2009 Feb; 7(2):163-7. PMID: 18929688.
      View in: PubMed
    104. Levine AJ, Wallace K, Tsang S, Haile RW, Saibil F, Ahnen D, Cole BF, Barry EL, Munroe DJ, Ali IU, Ueland P, Baron JA. MTHFR genotype and colorectal adenoma recurrence: data from a double-blind placebo-controlled clinical trial. Cancer Epidemiol Biomarkers Prev. 2008 Sep; 17(9):2409-15. PMID: 18768511; PMCID: PMC2692038.
    105. Figueiredo JC, Levine AJ, Grau MV, Midttun O, Ueland PM, Ahnen DJ, Barry EL, Tsang S, Munroe D, Ali I, Haile RW, Sandler RS, Baron JA. Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation. Cancer Epidemiol Biomarkers Prev. 2008 Aug; 17(8):2136-45. PMID: 18708408; PMCID: PMC2518404.
    106. Meyskens FL, McLaren CE, Pelot D, Fujikawa-Brooks S, Carpenter PM, Hawk E, Kelloff G, Lawson MJ, Kidao J, McCracken J, Albers CG, Ahnen DJ, Turgeon DK, Goldschmid S, Lance P, Hagedorn CH, Gillen DL, Gerner EW. Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res (Phila). 2008 Jun; 1(1):32-8. PMID: 18841250; PMCID: PMC2562024.
    107. DeBourcy AC, Lichtenberger S, Felton S, Butterfield KT, Ahnen DJ, Denberg TD. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med. 2008 Feb; 23(2):169-74. PMID: 18157581; PMCID: PMC2359177.
    108. Ahnen DJ, Guerciolini R, Hauptman J, Blotner S, Woods CJ, Wargovich MJ. Effect of orlistat on fecal fat, fecal biliary acids, and colonic cell proliferation in obese subjects. Clin Gastroenterol Hepatol. 2007 Nov; 5(11):1291-9. PMID: 17920338.
      View in: PubMed
    109. Lieberman DA, Weiss DG, Harford WV, Ahnen DJ, Provenzale D, Sontag SJ, Schnell TG, Chejfec G, Campbell DR, Kidao J, Bond JH, Nelson DB, Triadafilopoulos G, Ramirez FC, Collins JF, Johnston TK, McQuaid KR, Garewal H, Sampliner RE, Esquivel R, Robertson D. Five-year colon surveillance after screening colonoscopy. Gastroenterology. 2007 Oct; 133(4):1077-85. PMID: 17698067.
      View in: PubMed
    110. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, McKeown-Eyssen G, Summers RW, Rothstein RI, Burke CA, Snover DC, Church TR, Allen JI, Robertson DJ, Beck GJ, Bond JH, Byers T, Mandel JS, Mott LA, Pearson LH, Barry EL, Rees JR, Marcon N, Saibil F, Ueland PM, Greenberg ER. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007 Jun 06; 297(21):2351-9. PMID: 17551129.
      View in: PubMed
    111. O'Dwyer PJ, Eckhardt SG, Haller DG, Tepper J, Ahnen D, Hamilton S, Benson AB, Rothenberg M, Petrelli N, Lenz HJ, Diasio R, DuBois R, Sargent D, Sloan J, Johnson CD, Comis RL, O'Connell MJ. Priorities in colorectal cancer research: recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups. J Clin Oncol. 2007 Jun 01; 25(16):2313-21. PMID: 17538178.
      View in: PubMed
    112. Denberg TD, Coombes JM, Byers TE, Marcus AC, Feinberg LE, Steiner JF, Ahnen DJ. Effect of a mailed brochure on appointment-keeping for screening colonoscopy: a randomized trial. Ann Intern Med. 2006 Dec 19; 145(12):895-900. PMID: 17179058.
      View in: PubMed
    113. Levine JS, Ahnen DJ. Clinical practice. Adenomatous polyps of the colon. N Engl J Med. 2006 Dec 14; 355(24):2551-7. PMID: 17167138.
      View in: PubMed
    114. Barry EL, Baron JA, Bhat S, Grau MV, Burke CA, Sandler RS, Ahnen DJ, Haile RW, O'Brien TG. Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention. J Natl Cancer Inst. 2006 Oct 18; 98(20):1494-500. PMID: 17047198.
      View in: PubMed
    115. Einspahr JG, Martinez ME, Jiang R, Hsu CH, Rashid A, Bhattacharrya AK, Ahnen DJ, Jacobs ET, Houlihan PS, Webb CR, Alberts DS, Hamilton SR. Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics. Cancer Epidemiol Biomarkers Prev. 2006 Aug; 15(8):1443-50. PMID: 16896030; PMCID: PMC3547362.
    116. Rice PL, Peters SL, Beard KS, Ahnen DJ. Sulindac independently modulates extracellular signal-regulated kinase 1/2 and cyclic GMP-dependent protein kinase signaling pathways. Mol Cancer Ther. 2006 Mar; 5(3):746-54. PMID: 16546990.
      View in: PubMed
    117. Roth MJ, Hu N, Johnson LL, Quon-Hang W, Ahnen DJ, Iwamoto M, Dawsey SM, Taylor PR, Huppi K. beta-Catenin splice variants and downstream targets as markers for neoplastic progression of esophageal cancer. Genes Chromosomes Cancer. 2005 Dec; 44(4):423-8. PMID: 16114033.
      View in: PubMed
    118. Denberg TD, Melhado TV, Coombes JM, Beaty BL, Berman K, Byers TE, Marcus AC, Steiner JF, Ahnen DJ. Predictors of nonadherence to screening colonoscopy. J Gen Intern Med. 2005 Nov; 20(11):989-95. PMID: 16307622; PMCID: PMC1490266.
    119. Pangburn HA, Kraus H, Ahnen DJ, Rice PL. Sulindac metabolites inhibit epidermal growth factor receptor activation and expression. J Carcinog. 2005 Sep 02; 4:16. PMID: 16138927; PMCID: PMC1208922.
    120. Limburg PJ, Wei W, Ahnen DJ, Qiao Y, Hawk ET, Wang G, Giffen CA, Wang G, Roth MJ, Lu N, Korn EL, Ma Y, Caldwell KL, Dong Z, Taylor PR, Dawsey SM. Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxib. Gastroenterology. 2005 Sep; 129(3):863-73. PMID: 16143126.
      View in: PubMed
    121. Robertson DJ, Burke CA, Schwender BJ, Wargovich MJ, Greenberg ER, Sandler RS, Ahnen DJ, Rothstein R, Mott LA, Baron JA. Histamine receptor antagonists and incident colorectal adenomas. Aliment Pharmacol Ther. 2005 Jul 15; 22(2):123-8. PMID: 16011670.
      View in: PubMed
    122. Robertson DJ, Greenberg ER, Beach M, Sandler RS, Ahnen D, Haile RW, Burke CA, Snover DC, Bresalier RS, McKeown-Eyssen G, Mandel JS, Bond JH, Van Stolk RU, Summers RW, Rothstein R, Church TR, Cole BF, Byers T, Mott L, Baron JA. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology. 2005 Jul; 129(1):34-41. PMID: 16012932.
      View in: PubMed
    123. Wold KS, Byers T, Crane LA, Ahnen D. What do cancer survivors believe causes cancer? (United States). Cancer Causes Control. 2005 Mar; 16(2):115-23. PMID: 15868453.
      View in: PubMed
    124. Iwamoto M, Hoffenberg EJ, Carethers JM, Doctolero R, Tajima A, Sugano K, Franklin WA, Ahnen DJ. Nuclear accumulation of beta-catenin occurs commonly in the epithelial cells of juvenile polyps. Pediatr Res. 2005 Jan; 57(1):4-9; discussion 1-3. PMID: 15557107.
      View in: PubMed
    125. Rice PL, Beard KS, Driggers LJ, Ahnen DJ. Inhibition of extracellular-signal regulated kinases 1/2 is required for apoptosis of human colon cancer cells in vitro by sulindac metabolites. Cancer Res. 2004 Nov 15; 64(22):8148-51. PMID: 15548677.
      View in: PubMed
    126. Vernon SW, Meissner H, Klabunde C, Rimer BK, Ahnen DJ, Bastani R, Mandelson MT, Nadel MR, Sheinfeld-Gorin S, Zapka J. Measures for ascertaining use of colorectal cancer screening in behavioral, health services, and epidemiologic research. Cancer Epidemiol Biomarkers Prev. 2004 Jun; 13(6):898-905. PMID: 15184243.
      View in: PubMed
    127. Rice PL, Kelloff J, Sullivan H, Driggers LJ, Beard KS, Kuwada S, Piazza G, Ahnen DJ. Sulindac metabolites induce caspase- and proteasome-dependent degradation of beta-catenin protein in human colon cancer cells. Mol Cancer Ther. 2003 Sep; 2(9):885-92. PMID: 14555707.
      View in: PubMed
    128. Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, McKeown-Eyssen G, Summers RW, Rothstein R, Burke CA, Snover DC, Church TR, Allen JI, Beach M, Beck GJ, Bond JH, Byers T, Greenberg ER, Mandel JS, Marcon N, Mott LA, Pearson L, Saibil F, van Stolk RU. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 2003 Mar 06; 348(10):891-9. PMID: 12621133.
      View in: PubMed
    129. Lynch KL, Ahnen DJ, Byers T, Weiss DG, Lieberman DA. First-degree relatives of patients with advanced colorectal adenomas have an increased prevalence of colorectal cancer. Clin Gastroenterol Hepatol. 2003 Mar; 1(2):96-102. PMID: 15017501.
      View in: PubMed
    130. Rice PL, Washington M, Schleman S, Beard KS, Driggers LJ, Ahnen DJ. Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells. Cancer Res. 2003 Feb 01; 63(3):616-20. PMID: 12566304.
      View in: PubMed
    131. Markey K, Axel L, Ahnen D. Basic concepts for genetic testing in common hereditary colorectal cancer syndromes. Curr Gastroenterol Rep. 2002 Oct; 4(5):404-13. PMID: 12228043.
      View in: PubMed
    132. Gatof D, Ahnen D. Primary prevention of colorectal cancer: diet and drugs. Gastroenterol Clin North Am. 2002 Jun; 31(2):587-623, xi. PMID: 12134620.
      View in: PubMed
    133. Brock J, Sauaia A, Ahnen D, Marine W, Schluter W, Stevens BR, Scinto JD, Karp H, Bratzler D. Process of care and outcomes for elderly patients hospitalized with peptic ulcer disease: results from a quality improvement project. JAMA. 2001 Oct 24-31; 286(16):1985-93. PMID: 11667935.
      View in: PubMed
    134. Maltzman T, Knoll K, Martinez ME, Byers T, Stevens BR, Marshall JR, Reid ME, Einspahr J, Hart N, Bhattacharyya AK, Kramer CB, Sampliner R, Alberts DS, Ahnen DJ. Ki-ras proto-oncogene mutations in sporadic colorectal adenomas: relationship to histologic and clinical characteristics. Gastroenterology. 2001 Aug; 121(2):302-9. PMID: 11487539.
      View in: PubMed
    135. Spechler SJ, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F, Raufman JP, Sampliner R, Schnell T, Sontag S, Vlahcevic ZR, Young R, Williford W. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA. 2001 May 09; 285(18):2331-8. PMID: 11343480.
      View in: PubMed
    136. Rice PL, Goldberg RJ, Ray EC, Driggers LJ, Ahnen DJ. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites. Cancer Res. 2001 Feb 15; 61(4):1541-7. PMID: 11245463.
      View in: PubMed
    137. Ahnen DJ, Lynch KL. Colorectal cancer screening in average- and high-risk groups. Adv Intern Med. 2001; 46:77-106. PMID: 11147261.
      View in: PubMed
    138. Iwamoto M, Ahnen DJ, Franklin WA, Maltzman TH. Expression of beta-catenin and full-length APC protein in normal and neoplastic colonic tissues. Carcinogenesis. 2000 Nov; 21(11):1935-40. PMID: 11062151.
      View in: PubMed
    139. Shahrier M, Ahnen DJ. Colorectal cancer survival in Europe: the Will Rogers phenomenon revisited. Gut. 2000 Oct; 47(4):463-4. PMID: 10986203; PMCID: PMC1728087.
    140. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000 Jul 20; 343(3):162-8. PMID: 10900274.
      View in: PubMed
    141. Thompson WJ, Piazza GA, Li H, Liu L, Fetter J, Zhu B, Sperl G, Ahnen D, Pamukcu R. Exisulind induction of apoptosis involves guanosine 3',5'-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-catenin. Cancer Res. 2000 Jul 01; 60(13):3338-42. PMID: 10910034.
      View in: PubMed
    142. Laine L, Ahnen D, McClain C, Solcia E, Walsh JH. Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther. 2000 Jun; 14(6):651-68. PMID: 10848649.
      View in: PubMed
    143. Baier M, Calonge N, Cutter G, McClatchey M, Schoentgen S, Hines S, Marcus A, Ahnen D. Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiol Biomarkers Prev. 2000 Feb; 9(2):229-32. PMID: 10698488.
      View in: PubMed
    144. Martínez ME, Maltzman T, Marshall JR, Einspahr J, Reid ME, Sampliner R, Ahnen DJ, Hamilton SR, Alberts DS. Risk factors for Ki-ras protooncogene mutation in sporadic colorectal adenomas. Cancer Res. 1999 Oct 15; 59(20):5181-5. PMID: 10537295.
      View in: PubMed
    145. Ahnen DJ. Tissue markers of colon cancer risk. Gastrointest Endosc. 1999 Mar; 49(3 Pt 2):S50-9. PMID: 10049449.
      View in: PubMed
    146. Marcus AC, Ahnen D, Cutter G, Calonge N, Russell S, Sedlacek SM, Wood M, Manchester D, Fox L, McCaskill-Stevens W, Fairclough D, Hines S, Wenzel L, Osborn K. Promoting cancer screening among the first-degree relatives of breast and colorectal cancer patients: the design of two randomized trials. Prev Med. 1999 Mar; 28(3):229-42. PMID: 10072740.
      View in: PubMed
    147. Hoffenberg EJ, Sauaia A, Maltzman T, Knoll K, Ahnen DJ. Symptomatic colonic polyps in childhood: not so benign. J Pediatr Gastroenterol Nutr. 1999 Feb; 28(2):175-81. PMID: 9932851.
      View in: PubMed
    148. Brensinger JD, Laken SJ, Luce MC, Powell SM, Vance GH, Ahnen DJ, Petersen GM, Hamilton SR, Giardiello FM. Variable phenotype of familial adenomatous polyposis in pedigrees with 3' mutation in the APC gene. Gut. 1998 Oct; 43(4):548-52. PMID: 9824584; PMCID: PMC1727294.
    149. Karagas MR, Tosteson TD, Greenberg ER, Rothstein RI, Roebuck BD, Herrin M, Ahnen D. Effects of milk and milk products on rectal mucosal cell proliferation in humans. Cancer Epidemiol Biomarkers Prev. 1998 Sep; 7(9):757-66. PMID: 9752983.
      View in: PubMed
    150. Ahnen DJ, Byers T. Proliferation happens. JAMA. 1998 Sep 23-30; 280(12):1095-6. PMID: 9757861.
      View in: PubMed
    151. Malkinson AM, Koski KM, Dwyer-Nield LD, Rice PL, Rioux N, Castonguay A, Ahnen DJ, Thompson H, Pamukcu R, Piazza GA. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumor formation by FGN-1 (sulindac sulfone). Carcinogenesis. 1998 Aug; 19(8):1353-6. PMID: 9744528.
      View in: PubMed
    152. Ahnen DJ, Feigl P, Quan G, Fenoglio-Preiser C, Lovato LC, Bunn PA, Stemmerman G, Wells JD, Macdonald JS, Meyskens FL. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study. Cancer Res. 1998 Mar 15; 58(6):1149-58. PMID: 9515799.
      View in: PubMed
    153. Ahnen DJ. Colon cancer prevention by NSAIDs: what is the mechanism of action? Eur J Surg Suppl. 1998; (582):111-4. PMID: 10029375.
      View in: PubMed
    154. Arber N, Han EK, Sgambato A, Piazza GA, Delohery TM, Begemann M, Weghorst CM, Kim NH, Pamukcu R, Ahnen DJ, Reed JC, Weinstein IB, Holt PR. A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytes. Gastroenterology. 1997 Dec; 113(6):1892-900. PMID: 9394728.
      View in: PubMed
    155. Maltzman T, Whittington J, Driggers L, Stephens J, Ahnen D. AOM-induced mouse colon tumors do not express full-length APC protein. Carcinogenesis. 1997 Dec; 18(12):2435-9. PMID: 9450492.
      View in: PubMed
    156. Freston JW, Ahnen DJ, Czinn SJ, Earnest DL, Farthing MJ, Gorbach SL, Hunt RH, Sandler RS, Schuster MM. Review and analysis of the effects of olestra, a dietary fat substitute, on gastrointestinal function and symptoms. Regul Toxicol Pharmacol. 1997 Oct; 26(2):210-8. PMID: 9356284.
      View in: PubMed
    157. Park HS, Goodlad RA, Ahnen DJ, Winnett A, Sasieni P, Lee CY, Wright NA. Effects of epidermal growth factor and dimethylhydrazine on crypt size, cell proliferation, and crypt fission in the rat colon. Cell proliferation and crypt fission are controlled independently. Am J Pathol. 1997 Sep; 151(3):843-52. PMID: 9284833; PMCID: PMC1857833.
    158. Piazza GA, Alberts DS, Hixson LJ, Paranka NS, Li H, Finn T, Bogert C, Guillen JM, Brendel K, Gross PH, Sperl G, Ritchie J, Burt RW, Ellsworth L, Ahnen DJ, Pamukcu R. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res. 1997 Jul 15; 57(14):2909-15. PMID: 9230200.
      View in: PubMed
    159. Piazza GA, Rahm AK, Finn TS, Fryer BH, Li H, Stoumen AL, Pamukcu R, Ahnen DJ. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. Cancer Res. 1997 Jun 15; 57(12):2452-9. PMID: 9192825.
      View in: PubMed
    160. Erdman SH, Wu HD, Hixson LJ, Ahnen DJ, Gerner EW. Assessment of mutations in Ki-ras and p53 in colon cancers from azoxymethane- and dimethylhydrazine-treated rats. Mol Carcinog. 1997 Jun; 19(2):137-44. PMID: 9210960.
      View in: PubMed
    161. Thompson HJ, Jiang C, Lu J, Mehta RG, Piazza GA, Paranka NS, Pamukcu R, Ahnen DJ. Sulfone metabolite of sulindac inhibits mammary carcinogenesis. Cancer Res. 1997 Jan 15; 57(2):267-71. PMID: 9000566.
      View in: PubMed
    162. Tosteson TD, Karagas MR, Rothstein R, Ahnen DJ, Greenberg ER. Reliability of whole crypt mitotic count as a measure of cellular proliferation in rectal biopsies. Cancer Epidemiol Biomarkers Prev. 1996 Jun; 5(6):437-9. PMID: 8781739.
      View in: PubMed
    163. Ahnen DJ. Stalking the guardian of the genome: p53 in colorectal carcinogenesis. Am J Gastroenterol. 1996 Jan; 91(1):3-6. PMID: 8561139.
      View in: PubMed
    164. Ahnen DJ. The genetic basis of colorectal cancer risk. Adv Intern Med. 1996; 41:531-52. PMID: 8903598.
      View in: PubMed
    165. Thompson HJ, Briggs S, Paranka NS, Piazza GA, Brendel K, Gross PH, Sperl GJ, Pamukcu R, Ahnen DJ. Inhibition of mammary carcinogenesis in rats by sulfone metabolite of sulindac. J Natl Cancer Inst. 1995 Aug 16; 87(16):1259-60. PMID: 7563174.
      View in: PubMed
    166. Itzkowitz SH, Marshall A, Kornbluth A, Harpaz N, McHugh JB, Ahnen D, Sachar DB. Sialosyl-Tn antigen: initial report of a new marker of malignant progression in long-standing ulcerative colitis. Gastroenterology. 1995 Aug; 109(2):490-7. PMID: 7615198.
      View in: PubMed
    167. Alberts DS, Hixson L, Ahnen D, Bogert C, Einspahr J, Paranka N, Brendel K, Gross PH, Pamukcu R, Burt RW. Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase? J Cell Biochem Suppl. 1995; 22:18-23. PMID: 8538196.
      View in: PubMed
    168. Ahnen DJ, Poulsom R, Stamp GW, Elia G, Pike C, Jeffery R, Longcroft J, Rio MC, Chambon P, Wright NA. The ulceration-associated cell lineage (UACL) reiterates the Brunner's gland differentiation programme but acquires the proliferative organization of the gastric gland. J Pathol. 1994 Aug; 173(4):317-26. PMID: 7965391.
      View in: PubMed
    169. Ahnen DJ. Multi-phase chemoprevention of large bowel carcinogenesis. Am J Gastroenterol. 1993 Oct; 88(10):1647-9. PMID: 8213703.
      View in: PubMed
    170. Wright NA, Poulsom R, Stamp G, Van Noorden S, Sarraf C, Elia G, Ahnen D, Jeffery R, Longcroft J, Pike C, et al. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology. 1993 Jan; 104(1):12-20. PMID: 8419234.
      View in: PubMed
    171. Yamada K, Yoshitake K, Sato M, Ahnen DJ. Proliferating cell nuclear antigen expression in normal, preneoplastic, and neoplastic colonic epithelium of the rat. Gastroenterology. 1992 Jul; 103(1):160-7. PMID: 1351857.
      View in: PubMed
    172. Ahnen DJ. Abnormal DNA content as a biomarker of large bowel cancer risk and prognosis. J Cell Biochem Suppl. 1992; 16G:143-50. PMID: 1469894.
      View in: PubMed
    173. Ahnen DJ. Genetics of colon cancer. West J Med. 1991 Jun; 154(6):700-5. PMID: 1652174; PMCID: PMC1002870.
    174. Ahnen DJ. Lessons from the genetics of colon cancer. Scand J Gastroenterol Suppl. 1990; 175:166-76. PMID: 2173130.
      View in: PubMed
    175. Everson GT, Ahnen D, Harper PC, Krawitt EL. Benign recurrent intrahepatic cholestasis: treatment with S-adenosylmethionine. Gastroenterology. 1989 May; 96(5 Pt 1):1354-7. PMID: 2703120.
      View in: PubMed
    176. Ahnen DJ, Reed TA, Bozdech JM. Isolation and characterization of populations of mature and immature rat colonocytes. Am J Physiol. 1988 Apr; 254(4 Pt 1):G610-21. PMID: 3354680.
      View in: PubMed
    177. Sugiyama T, Brown WR, Ahnen DJ. Expression of cell-surface antigens on rat colonic cancer cells. Gastroenterology. 1988 Feb; 94(2):331-42. PMID: 3335310.
      View in: PubMed
    178. Ahnen DJ, Warren GH, Greene LJ, Singleton JW, Brown WR. Search for a specific marker of mucosal dysplasia in chronic ulcerative colitis. Gastroenterology. 1987 Dec; 93(6):1346-55. PMID: 2445617.
      View in: PubMed
    179. Ahnen DJ, Kinoshita K, Nakane PK, Brown WR. Differential expression carcinoembryonic antigen and secretory component during colonic epithelial cell differentiation and in colonic carcinomas. Gastroenterology. 1987 Dec; 93(6):1330-8. PMID: 3678752.
      View in: PubMed
    180. Meltzer SJ, Ahnen DJ, Battifora H, Yokota J, Cline MJ. Protooncogene abnormalities in colon cancers and adenomatous polyps. Gastroenterology. 1987 May; 92(5 Pt 1):1174-80. PMID: 3557013.
      View in: PubMed
    181. Shioda Y, Brown WR, Ahnen DJ. Serial observations of colonic carcinogenesis in the rat. Premalignant mucosa binds Ulex europeus agglutinin. Gastroenterology. 1987 Jan; 92(1):1-12. PMID: 2430852.
      View in: PubMed
    182. Ahnen DJ. Are animal models of colon cancer relevant to human disease. Dig Dis Sci. 1985 Dec; 30(12 Suppl):103S-106S. PMID: 4064871.
      View in: PubMed
    183. Boland CR, Ahnen DJ. Binding of lectins to goblet cell mucin in malignant and premalignant colonic epithelium in the CF-1 mouse. Gastroenterology. 1985 Jul; 89(1):127-37. PMID: 3891494.
      View in: PubMed
    Ahnen's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)